Repeated severe neonatal hemolysis due to Rhesus isoimmunization in a pregnant woman. 2002

Da-Chung Chen, and Yeing-Kuan Chang, and Wei-Hwa Chen, and Jah-Yao Liu
Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, 325, Section 2, Cheng-Kung Road, Nei-Hu, Taipei, Taiwan 114.

Rhesus (Rh) isoimmunization presenting as severe neonatal hemolytic disease is rare in RhD negative primigravidas of Chinese ethnicity. We report the case of a 32-year-old pregnant Taiwanese woman, RhD negative, who gave birth vaginally to two RhD-positive full-term fetuses 6 years apart. Antenatal follow-up was uneventful and there was no obvious fetal-maternal hemorrhage except at the performance of amniocentesis at the 19th week of the first pregnancy without anti-D immune globulin prophylaxis. Although anti-D immune globulins were administered to the mother within 1 hour after each birth, both of the newborns had severe neonatal hemolysis refractory to phototherapy and were rescued by exchange transfusions. Both of the children were well at age 7-years-old and one-year-old respectively In conclusion, with suspicion of fetal-maternal hemorrhage in RhD-negative pregnancies post amniocentesis, serial monitoring of indirect Coombs titer with appropriate management is mandatory.

UI MeSH Term Description Entries
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D005260 Female Females
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012203 Rh Isoimmunization The process by which fetal Rh+ erythrocytes enter the circulation of an Rh- mother, causing her to produce IMMUNOGLOBULIN G antibodies, which can cross the placenta and destroy the erythrocytes of Rh+ fetuses. Rh isoimmunization can also be caused by BLOOD TRANSFUSION with mismatched blood. Isoimmunization, Rhesus,Rh Sensitization,Isoimmunization, Rh,Isoimmunizations, Rh,Isoimmunizations, Rhesus,Rh Isoimmunizations,Rh Sensitizations,Rhesus Isoimmunization,Rhesus Isoimmunizations,Sensitization, Rh,Sensitizations, Rh
D012204 Rh-Hr Blood-Group System Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis. Rh Factors,Rhesus Blood-Group System,Antigen D, Rh Blood Group,Blood-Group System, Rh-Hr,Blood-Group System, Rhesus,Blood-Group Systems, Rh-Hr,Blood-Group Systems, Rhesus,Factor, Rh,Factors, Rh,Rh Factor,Rh Hr Blood Group System,Rh-Hr Blood-Group Systems,Rhesus Blood Group System,Rhesus Blood-Group Systems,System, Rh-Hr Blood-Group,System, Rhesus Blood-Group,Systems, Rh-Hr Blood-Group,Systems, Rhesus Blood-Group
D015514 Oncogene Proteins, Fusion The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular origin. Chimeric Oncogene Proteins,Chimeric Proteins, Oncogene,Fusion Proteins, Oncogene,Oncogene Fusion Proteins,Oncogene Proteins, Chimeric,Fusion Oncogene Proteins,Oncogene Chimeric Proteins,Proteins, Chimeric Oncogene,Proteins, Fusion Oncogene,Proteins, Oncogene Chimeric,Proteins, Oncogene Fusion

Related Publications

Da-Chung Chen, and Yeing-Kuan Chang, and Wei-Hwa Chen, and Jah-Yao Liu
January 1972, Journal de gynecologie, obstetrique et biologie de la reproduction,
Da-Chung Chen, and Yeing-Kuan Chang, and Wei-Hwa Chen, and Jah-Yao Liu
December 1992, Revue francaise de gynecologie et d'obstetrique,
Da-Chung Chen, and Yeing-Kuan Chang, and Wei-Hwa Chen, and Jah-Yao Liu
May 1997, Pediatric research,
Da-Chung Chen, and Yeing-Kuan Chang, and Wei-Hwa Chen, and Jah-Yao Liu
June 1968, Minerva medica,
Da-Chung Chen, and Yeing-Kuan Chang, and Wei-Hwa Chen, and Jah-Yao Liu
September 1972, Nederlands tijdschrift voor geneeskunde,
Da-Chung Chen, and Yeing-Kuan Chang, and Wei-Hwa Chen, and Jah-Yao Liu
June 1982, LARC medical,
Da-Chung Chen, and Yeing-Kuan Chang, and Wei-Hwa Chen, and Jah-Yao Liu
February 1960, Blood,
Da-Chung Chen, and Yeing-Kuan Chang, and Wei-Hwa Chen, and Jah-Yao Liu
April 1979, The Quarterly journal of medicine,
Da-Chung Chen, and Yeing-Kuan Chang, and Wei-Hwa Chen, and Jah-Yao Liu
October 2017, Medecine et maladies infectieuses,
Da-Chung Chen, and Yeing-Kuan Chang, and Wei-Hwa Chen, and Jah-Yao Liu
January 2003, Atencion primaria,
Copied contents to your clipboard!